A Study of FDA022-BB05 in Advanced/Metastatic Solid Tumors

Clinical trial NCT06413615 · UNKNOWN

Trial details

NCT number: NCT06413615
Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-05-13
Primary completion: 2025-07-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.